Chiasma Inc (CHMA)

NASDAQ
3.760
0.000(0.00%)
  • Volume:
    0
  • Day's Range:
    3.760 - 4.100
  • 52 wk Range:
    3.760 - 4.930

CHMA Overview

Prev. Close
4
Day's Range
3.76-4.1
Revenue
3.02M
Open
4.08
52 wk Range
3.76-4.93
EPS
-1.6
Volume
0
Market Cap
237.81M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
935,982
P/E Ratio
-
Beta
1.26
1-Year Change
-13.56%
Shares Outstanding
63,247,398
Next Earnings Date
-
What is your sentiment on Chiasma Inc?
or
Market is currently closed. Voting is open during market hours.

Chiasma Inc Analysis

Chiasma Inc Company Profile

Chiasma Inc Company Profile

Employees
85

Chiasma, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing oral medications using transient permeability enhancer technology platform for the treatment of rare and serious chronic disease worldwide. The company offers MYCAPSSA, an oral octreotide capsule for the long-term maintenance treatment in acromegaly patients who have responded to and tolerated treatment with octreotide or lanreotide. It also develops MPOWERED, an oral octreotide capsule, which has completed Phase III clinical trials for the maintenance treatment of adult patients with acromegaly. Chiasma, Inc. was incorporated in 2001 and is headquartered in Needham, Massachusetts.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving Averages
Technical Indicators
Summary
  • Going up.....now
    0
    • Bad!!!!
      1
      • can anyone explain the drop
        0
        • What happened? FDA approval !!why drop?
          0